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Malaria is a life-threatening disease caused by parasites 
that are transmitted to people through the bites of infected 
female Anopheles mosquitoes. There are 5 species 
malaria in human: Plasmodium vivax, P. falciparum, P. 
malariae, P. ovale and P. knowlesi. Geographic 
distribution of this disease is unique, especially region 
close to the equator. Even though potentially lethal, 
actually, it is preventable and curable.1-3 
During 2018, a rough estimation counts 228 million cases 
of malaria worldwide. The estimated number of malaria 
related morbidity as many as 405 000 in 2018. Children, 
especially aged under 5 years are the most vulnerable 
group affected by malaria.1,2 Global malaria cases already 
reduced slowly, even though the rate of decline is not as 
fast as expected.1 Morbidity and mortality due to malaria 
in endemic countries, including some part of Indonesia, 
still found.2 Children and pregnant women are among the 
most vulnerable group.3,4  
The majority of malarial infections to some extent are 
associated with various degree of anemia.5 Its severity 
relies upon two conditions patient-related properties (e.g., 
gender, age, innate and acquired resistance for people 
living in endemic areas, comorbid) and also parasite-
specific characteristics (eg, species of malaria infected, 
adhesiveness to the smaller vessels, and drug-resistance 
phenotype).6,7 Anemia related malaria is capable of 
causing collateral, mild to even severe, morbidity and 
mortality, especially in vulnerable groups, e.g. children 
and pregnant women.8-10 The most severe form of anemia 
in malaria named severe malarial anemia (SMA).5,8 
Comorbidities, e.g helminthiasis, malnutrition, HIV, 
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tuberculosis etc made the problem become more complex 
to solve.11,12 
In Indonesia, due to its wide geographical coverage and 
the lack of documentation or publication, the study of 
malaria related anemia has somewhat typically under-
reported, belatedly, rarely and not thoroughly; even 
though that the result still give an excellent information 
needed not just by the academics and the clinicians, but to 
even to tourism practitioner, because some of Indonesia’s 
best tourism destination located in region considered to 
be malaria endemic.13-15 Publication on this topics could 
improve awareness and precaution.16 The primary aim of 
this literature study is to review the incidence of anemia 
among Indonesia’s malaria patients published in the 
internet, their geographic location and its related factors 
stated in the published studies that might consider 
contributing to the occurrence of anemia. 
METHODS 
The author did the literature searching on the internet 
using popular search engine Google™, Yahoo™ and 
Google Scholar™. The phrase used were “Malaria 
Anemia Indonesia pdf”, “Anemia pada Malaria di 
Indonesia pdf”, “Kasus Anemia pada Malaria di 
Indonesia pdf“, “Malarial Anemia in Indonesia pdf” and 
“Anemia among Malaria case in Indonesia pdf”. 
combination the search term in Bahasa 
Indonesia/Indonesian language and in English were 
conducted.  
This literature searching conducted from July 27th to 
August 2nd 2020. Potential article was sorted based on the 
type of the article which must be research article or 
original article, the tittle and content of the abstract and 
then saved for further analysis. Thorough and careful 
reading was done in order to make sure that the potential 
article actually revealed the incidence of anemia on their 
report. Factors that might contribute to the occurrence of 
anemia were also screened. A brief note when considered 
necessary was made on these findings and will be 
presented in the form of a summary table. 
RESULTS 
From hundreds of article collected, potential articles 
shorten into dozens and the final number of article which 
is assesed by the author personally are 37 articles. Out of 
these 37 studies, some conducted by bachelor degree 
students as their final thesis, and some were conducted by 
health professional that taking care the malaria (+) patient 
and some conducted by researcher from ministries of 
Health. Some studies, especially those conducted in 
Papua were collaboration study with foreign researcher. 
All 37 studies about anemia related malaria showed us 
that the spectrum of anemia as a consequences of malaria 
took place since the very early phase of infection, 
eventhough the clinical manifestation may occur 
gradually. From all these studies (n=37) most of the study 
design were cross sectional (36/97.29%). A study 
conducted by Taylor et al have a cohort/prospective study 
design. The number of the respondents also varies from 
just  dozens (e.g. Masengi et al) to  hundred of thousands, 
and in all studies  entangle both gender.  
Out of these 37 studies, the data on 13 studies  (35.13%) 
come from the subject infant, baby, toddler, children or 
<18 years old individuals. There are 5 studies (13.51%) 
with the subject were pregnant women and even one of 
these studies observed the outcome to that pregnancies. 
Even though most of these studies conducted on more 
diverse population. Table 1 list the summary of the 
findings in 37 studies conducted in some endemic areas in 
Indonesia concerning malarial related anemia.  
The number of studies conducted on hospitalized or 
outpatient from Primary health care facility or hospital 
are 25 (67.56%), while community or population-based 
studies as many as 12 (32.44%). Time of study ranging 
from 2001 conducted by Yusroh et al in Mandailing 
Natal, North Sumatera (western part of Indonesia) and the 
most recent study conducted by Patriani et al in Southern 
Papua (eastern part of Indonesia), last year (2019). 
From those 37 articles, in brief can be classified due to 
the geographic distribution based on major big island of 
Indonesia, namely Sumatra, Jawa/Java, 
Kalimantan/Borneo, Sulawesi, Ambon, Nusa Tenggara 
and Papua. Article no. 1-5 published data from Sumatra, 
article no. 6 from Java, article no. 7-8 from 
Kalimantan/Borneo, article no. 8-17 from Sulawesi, 
article 18-19 from Ambon, article no. 20-27 from Nusa 
Tenggara, article no. 28-37 conducted in Papua. From all 
5 big island, Papua contributes the highest in number of 
studies (10/37=27.02%). 
 
Figure 1: Recent map of malaria endemicity in 
Indonesia, 2018. We modified the map by adding 
arrow and number. Area pointed with arrow which 
studies conducted according to their sequence number 
listed in Tables 1, range from the year 2001-2019. (A-
G) Are the big island in Indonesia, namely (A) 
Sumatra, (B) Jawa/Jawa, (C) Kalimantan/Borneo, (D) 
Sulawesi/Celebes, (E) Ambon islands, (F) Nusa 
Tenggara and (G) Papua, with modification.13 
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Yusroh et al17 
(2001) 
Cross sectional and 
primary health care 
based 
67 children malaria (+), 
aged <15 years old 
 
P. vivax 49/67 =73.13% mean Hb 10.41 g/dL 
P.  falciparum 18/67=26.86% mean Hb 10.46 g/dL 
Malaria based on gender 
• Vivax Male 8/18=44.44%, Female10/18=63,56% 
• Falciparum Male 29/49=59.18%, Female 40.81% 







Cross sectional and 
hospital based 
76 patient’s malaria (+) 
P. vivax 73/76=96.05%, P. falciparum 3.95% 
Gender: male 46 (60.53%), female 30 (39.47%) 
• Anemia 21/76=27.63% 
• Mild 12/21=57.14% 
• Moderate 8/21=38.09% 
• Severe 1/21=4.76% 






Cross sectional and 
primary health care 
based 
326 patient’s malaria 
positive 
Anemia 165/326=50.61% 
Gender of Malaria (+) with anemia (+) patient 
• Male 141/165= 85.45%  
• Female 24/165= 14.55% 
Anemia more prominent on male patient 
Anemia based on type of malaria 
• P. vivax 16/165=9.69% 
• P. falciparum 113/165=68.48% 






Cross sectional and 
primary health care 
based 
55 pregnant women with 
history of malaria 
Microscopic findings 3/55=5.45% malaria (+) 
All malaria (+) also suffer from anemia (+) 
Malaria (+) pregnant women 
• All suffer from anemia 
• All had low TIBC 







primary health care 
based  
40 patients of malaria (+) 
 
Mean Hb among malaria (+) with anemia (+) 
• Mild anemia 11.66 g/dl 
• Moderate 8.72 g/dl 
• Severe 5.25 g/dl 
Negative correlation between parasitemia and anemia 
Continued. 
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62 children with clinical 
history of malaria 
19/62=30.64% anemia (+) 
29/62=46.77% experienced recent clinical malaria 
7 






Cross sectional and 
population based 
30 pregnant womens 
Mild anemia 8/22=26,7% among pregnant women who used insecticide-









patient care based 
206 patients 
• Vivax (+) 87 
• Falciparum (+) 
119 
• Mixed (+) 23 
Mean Hb for P. vivax and P. falciparum 10g/dL 
Fever in malaria vivax 31/87=35.63%, malaria falciparum 
63/119=52.94% 









50 patients with clinical 
symptom of malaria 
5/50=10% malaria (+) microscopically 
All malaria (+) suffer from anemia 









150 patients with clinical 
diagnosis of suspect    
Malaria 
78/150=52% malaria (+) microscopically 
Sensitivity of Anemia 76.9% and specificity of Anemia 59.7%, 
accuration rate 68.7% 
Statistically, Anemia is the most correlated clinical sign of malaria with 
the result of microscopic examination 
In attempt to diagnosis malaria clinically, shivering and clinical anemia 










75 malaria (+) children 
<15 years old 
Male 40/75=53.3%, Female 35/75=46.7% Aged 1-4 years old 
26/75=34.7% 
Anemia 43/75=57.3% 
Type of malaria      
• Vivax 49/75=65.3% 
• Falciparum 13/75=17.3% 











9/110=8.18% Malaria (+) microscopically 










105, children age 7-12 
years old 
79/105=75.2% malaria (+) microscopically, male 49 (62%), female 30 
(38%); age 7-9: 17 (21.5%) and age 10-12: 62 (78.5%)  




Ansar et al30 
(2014) 
Cross sectional, 
combination of both 





60/314=19.1% had history of Malaria 
94/314=29,9% anemia 
27/60=45.1% who had history of malaria suffer from anemia 
Continued. 
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148 (+) severe  
malaria falciparum 
Age between 1 month-13 years old 
75/148= 50.67% Male, 73/148=49.32% female 










92 children age 0-18 years 
old 
58/92=63% malaria falciparum,18/92=37% malaria vivax 
Age 5-9 years 29/92=31.5% 
Gender: 61/92=66% male, 31/92=34% female 
Anemia: 1/92=1.1% suffer from anemia (+) 
17 








women) based on 
data of 2013-2018 
11 pregnant women  
malaria (+) 
Prevalence  
• 6/11=55% malaria tertian/vivax (+) 
• 5/11=45% malaria tropika/falciparum (+) 
Complication: 2/6=33% pregnancy related malaria tertian/vivax ended 
with prematurity, 1/6=16.66% pregnancy related malaria tertian/vivax 
ended with asphyxia 
Anemia    
• 2/6=33% malaria tertian/vivax  
• 2/5=40% malaria tropika/falciparum  





based data  
 
61 malaria (+) patient 
Gender 
• 35/61= 52.9% male  
• 26/61= 47.1% Female 









83 pregnant women on the 
3rd semester 
19/83=22.89% pregnant women suffer from anemia due to malaria or 
malaria infection that can caused anemia 20.2  
20 
West Sumba, Nusa 
Tenggara timur 




1197 Indonesian school 
children, aged 5-15 years 
73/1197= 6.1% had asymptomatic P. falciparum with mean Hb 12.62 
g/dL and 18/1197=1.5% asymptomatic P. vivax parasitemia with mean 
Hb 12.2 g/dL 







Case control of 181 
malaria (+) vs181 
malaria (-), primary 
health care based 
362 individuals 
 
64/181=35.4% were suffer from anemia male 78/181=43.1%, female 
103/181=56.9% 
Age: <40 66/181=36.46%, ≥40 115/181=63.53% 








Case control and 
primary health care 
20 malaria vivax (+), 20 
malaria  
falciparum (+), 20 control 
malaria (-) 
Mean Hb    
• Malaria falciparum 10.5g/dl 
• Malaria vivax 12.2g/dl 
Mean density of parasite is higher in falciparum group  
Continued. 
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Fitri et al39 
(2014) 
Cross sectional and 
hospital based 
112 pair mother-infants, 
92 evaluated for further 
analysis 
Prevalence of congenital malaria in the endemic area 39/92=42.39% 
malaria (+), asymptomatic 
21/39=53.84% malaria (+) suffer from anemia and 20/39=51,28% 
malaria (+) asymptomatic were looks ill 









262 hospitalized malaria 
(+) patient 
Male 123/262=46.9%, Female=139/262=53.1% 
Age >15 years old 143/262=54.58% 
Malaria falciparum 210/262=80.15%, malaria vivax 52/262=19.84% 











555 healthy individual, 
aged >14 years, using 
nested PCR 
Total 181/555=32.61% malaria (+), malaria falciparum 57/181=31.49%, 
malaria vivax 94/181=51.93% and mixed infection 30/181=16.57% 
Anemia (Hb≤10g/dL) malaria falciparum 34/57=59.64%, malaria vivax   








using secondary data 
in 2013-2014 from 5 
sub-districts in 
South Central Timor 
Regency 
152 malaria (+) individual 
Malaria vivax 95/152=62.5%, Malaria falciparum 57/152=37.5% 
Anemia (Hb ≤11.23 g/dL) 75/152=49.34%, mean Hb 
vivax 43/75=57.33%, mean Hb 11.29 g/dl, falciparum 42.66% and mean 
Hb 11.13g/dL 









September 2013 to 
February 2014 
71 malaria tropical 
/malaria falciparum (+) 
individual  
Gender: male 35/71=49.29%, Female 36/71=50.70% 
Febris (37,50-400C) 46/71= 64.78% 
Anemia 25/71=35.21%, mean Hb 11.65g/dl mild (8-11g/dl) 18/25=72%, 
moderate (6-8g/dL) 5/25=20% and severe (<6g/dL) 2/25=8% 
28 Jayapura, Papua 




data based and 
regression modelling 
160 malaria (+) 
abnormal Hb level 80/160=50% 
abnormal Hb level at the age ≥40 75/80=93.75%, and < 40 5/80=6.25% 
Variables that contributes to anemia age, gender, nutritional status and 
age is the most significant 





based patient  
45 toddlers 
anemia 39/45=86.66% 
Malaria (+) 25/45=55.55% 










533 blood film collected 
malaria vivax 47/533=8.8% malaria falciparum 21/533= 3.9% 
105/269=39.03% soil transmitted helminth/STH (+) 
Those with STH (+) were at significantly greater risk of suffer from P. 
vivax parasitemia  
Anaemia (Hb<10 g/dl) was present in 24.5% (122/497) of children and 
associated with P. vivax parasitemia, P. falciparum parasitemia, 
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31 
Jayapura, Northeast 
Papua and Papua 





prospectively at day 
0, 3, 7 and 28 
n=57 indigenous Papuan 
and 105 non-Papuan with 
limited malaria exposure, 
treated with chloroquine, 
doxycycline or both for 
acute non complicated 
malaria vivax (n=64) and 
malaria falciparum (n=98) 
Mean initial Hb 12.7g/dL (similar in both group), even though in vivax 
group, the Papuan group had lower baseline HB compared to the non-
Papuan group 
Hb recovery related to baseline Hb 
Vivax infected malaria immune Papuan had  
persistently lower Hb concentrations compared to non-Papuan with 









secondary data of 
laboratory and 
clinical data from 
April 2004 to 
December 2012 
219, 845 Hb measured 
malaria falciparum:89,748 clinical events, 44, 171 patients 
malaria vivax: 54, 495 clinical events, 28, 841 patients 
mixed: 19, 569 clinical events from 14, 206 patients 
Anemia 
• Mild (<10 g/ dl): 97,665/219,845=44.4% 
• Moderate (7-10 g/dl): 27,106/219,845=12.3% 
• Severe (<5g/dL): 8,151/219,845=3.7% 









to determine the 
proportion of anemia 
severity (Hb <7 g/dl) 
attributable to patent 
P. vivax, P. 
falciparum and 
mixed parasitemia in 
Papua, Indonesia 
3890 blood sample 
Malaria type 
• Falciparum: 315 (8.1%) 
• Vivax: 250 (6.4%) 
• Mixed: 72 (1.9%) 
Mean reduction in hemoglobin 
• Malaria falciparum: 1.16 g/dl  
• Malaria vivax: 0.66 g/dl 
• Mixed: 1.25 g/dl 
Hb concentrations <7 g/dl in the community were estimated to be 
attributable to patent parasitemia 
Plasmodium vivax was associated with a greater than three-fold higher 













available in 215,479 
patients, 66,421 
(30.8%) of whom 
had clinical malaria 
215,479 patients 
7931/215 044=3.68% had severe anemia  
1484/7931=18.7% had the risk of severe thrombocytopenia among 
patients with severe anemia  
The overall adjusted population fraction of severe thrombocytopenia 
attributable to P. falciparum infection was 35.9%, P. vivax was 9.1% and 
mixed infections was 7.0% 
Severe anemia is an important prognostic indicator of fatal outcome, 
particularly in young children 
Continued. 
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malaria (April 2004 
to December 2013) 
15,716 children 
Prevalence 
• P. falciparum 6184/15,716=39.3%  
• P. vivax 7499/15,716=47.7%  
• P. malariae 203/15,716=1.3%  
• P. ovale 3/15,716=0,00019% 
• Mixed infections 1827 (11.6%) 
Within 1 year, 48.4% (7620/15,716) of children represented a total of 
16,957 times with malaria (range 1 to 11 episodes)  
the incidence of malaria being greater in patients initially presenting with 
P. vivax group 
Mortality after initial presentation 266/15,716=1.7% within 1 year, 
129/15,716=0.82% within 30 days. 137/15,716=0.87% between 31 and 
365 days, no significant difference in the mortality risk in patients 
infected with P. vivax versus P. falciparum either before 30 days or 
between 31 and 365 days 
children <5 years with malaria vivax are at significant risk of multiple 





et al52 (2016) 
Cross sectional 
hospitalized and out 
patients 
45 children 
Gender: 25/45=55.45 boys, 20/40=44.45% girls, 24/45=53.3% affected 
were between 1-5 years old. 30/45=66.7% malaria falciparum/tropical 
(+), 25/45= 55.6% anemia (+), Hb ranging 8-10 gram/dl and 19/45= 





et al53 (2009) 
Cross sectional 
To define malaria 
morbidity in the first 
year of life in an 
area where both 
multidrug-resistant 
P. falciparum 
and P. vivax are 
highly prevalent, 
data of all infants 
attending a referral 
hospital in 
Papua, Indonesia 
4976 infants hospitalized 
1560/4976=31.35% malaria (+) 102/187=56% had malaria vivax, and 
55/187=29.41% had malaria falciparum infection equally attributable to 
both types of malaria. The case-fatality rate was similar for inpatients 
with malaria falciparum (13/599=2.2% inpatients died) and malaria vivax 
(6/603=1.0% died) severe malarial anemia was more prevalent in malaria 
vivax (193/605=32% vs 144/601=24%) and that was associated with a 
greater risk of anemia. In these young infants, infection with P. vivax was 
associated with a greater risk of severe anemia and severe 
thrombocytopenia compared to malaria falciparum. 
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Anemia caused by malaria reported in these studies also 
varies, from mild anemia with minimal subjective 
complaint from the patients to the severe form of anemia 
that can endangered the live of the patient. 
DISCUSSION 
Severe malarial anemia (SMA) surely marks concern as a 
major public health problem because of the burdens of the 
affected children and also pregnant women.9,10 It is 
possibly that these numbers may escalate as the 
consequences of several reasons, e.g. difficulty in making 
correct diagnosis, drug unavailability, potency of drug 
resistance  phylogeny spreads, limitation of medical 
devices, remoteness of an area that making the health 
personal difficult to transfer/refer patient and possible 
comorbidities. If we look back to the Figure 1, Indonesia 
is an archipelago consists of 13.600+ islands, with a very 
wide area and different topograhic condition. The 
remoteness of an area, especially if that area is malaria 
endemic, is going to complicate the patient management, 
e.g. in case the doctors want to refer the patient to a more 
advanced health care facility. 
Concerns have also been raised by data from recent 
epidemiological studies, which reported this severity 
related to other comorbidities. Malaria and anemia, both 
alos increase the host’s susceptibility to other secondary 
infection.11,12 Even for such people living in endemic 
areas that already have acquired protection from acute 
infection, they still may succumb to severe anemia during 
a subacute or chronic phase of infection.1,15 Transfusing 
blood into such patient and managing them collectively 
and supportively also a very big challange.1,2 
The availability of electronic data on anemia related 
malaria in Indonesia is still sparse and detached. A more 
hollistic surveillance needed with emphasize on its 
comorbidities, vulnerable groups, anti-malaria treatment 
given and how well the patient recover. 
Fatality or mortality due to severe malaria anemia should  
have prevented earlier.1 By making correct  diagnosis as 
soon as possible and then start prompt treatment, 
complication can be avoid.8-10 In a community 
perspective, preventing recurrent malaria must be a public 
health  priority in this vulnerable population.51 Preventive 
strategies, early diagnosis, and prompt treatment should 
be initiated in the correct time appropriately by all stake 
holder.1 By actively reducing the number of cases seems 
to be easier than sustained elimination.2 All of this effort 
if conducted simultaneously can paved the way for 
malaria eradication.1,2 
CONCLUSION  
This brief literature study has revealed the condition of 
anemia related malaria from cases reported in Indonesia 
from 2001-2019. Eventhough many achievement have 
been done so far, these studies also informed us that 
malaria still a big parasito-epidemiology problem in 
Indonesia. Prevention of transmission and proper 
management of malaria needed in order to avoid worse 
case scenario of severe malaria and its complication. 
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